Aladdin Healthcare Technologies SE Logo

Aladdin Healthcare Technologies SE

NMI | BE

Overview

Corporate Details

ISIN(s):
DE000A12ULL2
LEI:
391200M0N1PWTP19RE15
Country:
Germany
Address:
Unter den Linden 10, 10117 Berlin
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Aladdin Healthcare Technologies SE is a developer of artificial intelligence (AI) solutions for the healthcare sector, specializing in diagnostics and drug discovery for age-related diseases. The company leverages its proprietary AI and deep learning technologies across three core platforms: Drug Discovery, Biomedical Knowledge Graphs, and Disease Diagnosis. Its applications aim to accelerate the discovery of novel therapeutics and enhance disease detection through advanced analysis of medical data, including image processing. Key areas of focus include developing new compounds for conditions like Alzheimer's and creating automated diagnostic tools for medical imaging.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Aladdin Healthcare Technologies SE. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2022-09-02 16:41
Legal Proceedings Report
Aladdin Healthcare Technologies SE: Antrag auf Eroffnung eines Insolvenzverfahr…
German 4.8 KB
2022-08-15 13:30
Legal Proceedings Report
Aladdin Healthcare Technologies SE: Notice of fine by BaFin in the total amoun…
English 5.1 KB
2022-02-02 16:46
Declaration of Voting Results & Voting Rights Announcements
English 15.1 KB
2022-02-02 15:25
Director's Dealing
DGAP-DD: Aladdin Healthcare Technologies SE english
English 7.7 KB
2022-02-01 17:01
Declaration of Voting Results & Voting Rights Announcements
English 14.2 KB
2022-02-01 15:54
Declaration of Voting Results & Voting Rights Announcements
English 14.1 KB
2021-12-03 10:51
Declaration of Voting Results & Voting Rights Announcements
English 14.2 KB
2021-11-24 09:00
Regulatory News Service
Aladdin Healthcare Technologies SE approved for Listing on OTCQB in the USA
English 8.7 KB
2021-11-03 09:00
Report Publication Announcement
English 3.5 KB
2021-11-02 16:51
Declaration of Voting Results & Voting Rights Announcements
English 15.2 KB
2021-11-02 16:47
Declaration of Voting Results & Voting Rights Announcements
English 13.9 KB
2021-09-28 11:35
Report Publication Announcement
English 3.9 KB
2021-09-23 18:41
Declaration of Voting Results & Voting Rights Announcements
English 15.1 KB
2021-09-20 19:34
Director's Dealing
DGAP-DD: Aladdin Healthcare Technologies SE english
English 7.6 KB
2021-07-14 08:36
Regulatory News Service
Aladdin Healthcare Technologies with new research findings on COVID-19 diagnosis
English 10.2 KB

Automate Your Workflow. Get a real-time feed of all Aladdin Healthcare Technologies SE filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Aladdin Healthcare Technologies SE via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-02-02 Menpes-Smith, Mr Wade Board Other None 211,425.00 EUR
2021-09-21 Continental Aktiengesellschaft Close relation Sell None 243,288.00 EUR
2021-09-20 Smith, Wade Board Other None 211,425.00 EUR

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN